Bristol Myers Squibb Co. (BMY)
59.12
-0.46
(-0.77%)
USD |
NYSE |
Oct 09, 16:00
59.20
+0.08
(+0.14%)
After-Hours: 20:00
Bristol Myers Squibb Free Cash Flow (Quarterly) : 3.088B for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.088B |
| March 31, 2026 | 757.00M |
| December 31, 2025 | 1.604B |
| September 30, 2025 | 5.991B |
| June 30, 2025 | 3.556B |
| March 31, 2025 | 1.694B |
| December 31, 2024 | 4.061B |
| September 30, 2024 | 5.267B |
| June 30, 2024 | 2.064B |
| March 31, 2024 | 2.55B |
| December 31, 2023 | 3.922B |
| September 30, 2023 | 4.409B |
| June 30, 2023 | 1.628B |
| March 31, 2023 | 2.692B |
| December 31, 2022 | 2.96B |
| September 30, 2022 | 3.44B |
| June 30, 2022 | 1.989B |
| March 31, 2022 | 3.559B |
| December 31, 2021 | 3.737B |
| September 30, 2021 | 4.996B |
| June 30, 2021 | 2.85B |
| March 31, 2021 | 3.651B |
| December 31, 2020 | 3.387B |
| September 30, 2020 | 2.066B |
| June 30, 2020 | 4.138B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.708B |
| December 31, 2019 | 1.787B |
| September 30, 2019 | 2.366B |
| June 30, 2019 | 1.892B |
| March 31, 2019 | 1.186B |
| December 31, 2018 | 2.139B |
| September 30, 2018 | 1.055B |
| June 30, 2018 | 859.00M |
| March 31, 2018 | 936.00M |
| December 31, 2017 | 863.00M |
| September 30, 2017 | 1.451B |
| June 30, 2017 | 1.336B |
| March 31, 2017 | 570.00M |
| December 31, 2016 | 1.057B |
| September 30, 2016 | 1.056B |
| June 30, 2016 | 150.00M |
| March 31, 2016 | -628.00M |
| December 31, 2015 | 326.00M |
| September 30, 2015 | 290.00M |
| June 30, 2015 | -94.00M |
| March 31, 2015 | 490.00M |
| December 31, 2014 | 381.00M |
| September 30, 2014 | 796.00M |
| June 30, 2014 | 946.00M |
| March 31, 2014 | 499.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Johnson & Johnson | 7.295B |
| Eli Lilly & Co. | 4.475B |
| Merck & Co., Inc. | 4.477B |
| Pfizer Inc. | 302.00M |
| AstraZeneca PLC | 1.885B |